🔎 Trials Near Me

Gara Jalqabaatti › Dhibee Qara › Michigan › Ann Arbor

Qorannoo klinikaalii Dhibee Qara Ann Arbor, MI keessatti

Qorannoo 23 Dhibee Qara f Ann Arbor fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial

Namoota walitti qabaa jiraSadarkaa 3
  • Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · Miili 7 fagaatti
  • Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea · Miili 15 fagaatti
  • Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton · Miili 18 fagaatti
Umuriin 70 fi ol · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT06096844

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Namoota walitti qabaa jiraSadarkaa 3
  • Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
  • Huron Gastroenterology PC, Ypsilanti · Miili 7 fagaatti
  • Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · Miili 7 fagaatti
  • fi 4 dabalataa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT04267848

Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer

Namoota walitti qabaa jiraSadarkaa 3
  • Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
  • Huron Gastroenterology PC, Ypsilanti · Miili 7 fagaatti
  • Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · Miili 7 fagaatti
  • fi 4 dabalataa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT04181060

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
  • Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
  • Huron Gastroenterology PC, Ypsilanti · Miili 7 fagaatti
  • Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · Miili 7 fagaatti
  • fi 4 dabalataa
Umuriin 40 hanga 75 · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT05334069

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

Namoota walitti qabaa jiraSadarkaa 3
  • University of Michigan Rogel Cancer Center, Ann Arbor
  • Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · Miili 7 fagaatti
  • Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea · Miili 15 fagaatti
  • fi 2 dabalataa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT06498635

Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)

Namoota walitti qabaa jiraSadarkaa 3
  • Trinity Health Ann Arbor Hospital, Ann Arbor
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 29-Ful-2026 · NCT06881784

A Registry for People With Lung Cancer

Namoota walitti qabaa jiraQorannoo ilaalaa
  • University of Michigan (Data Collection Only), Ann Arbor
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 24-Ful-2026 · NCT06424327

A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations

Namoota walitti qabaa jiraSadarkaa 1/2
  • University of Michigan Medical School Rogel Cancer Center, Ann Arbor
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 21-Ful-2026 · NCT07629960

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

Namoota walitti qabaa jiraSadarkaa 3
  • University of Michigan, Ann Arbor
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 08-Ful-2026 · NCT06119581

Evaluation of the Safety and Efficacy of Abenacianine (VGT-309) to Identify Cancer in Subjects Undergoing Surgery for Cancer in the Lung

Namoota walitti qabaa jiraSadarkaa 3
  • University of Michigan, Ann Arbor
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 19-Hag-2026 · NCT07499674

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

Namoota walitti qabaa jiraSadarkaa 3
  • Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
  • Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · Miili 7 fagaatti
  • Chelsea Hospital, Chelsea · Miili 15 fagaatti
  • fi 3 dabalataa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 17-Hag-2026 · NCT05624996

Gilteritinib for the Treatment of ALK NSCLC

Namoota walitti qabaa jiraSadarkaa 1
  • University of Michigan Comprehensive Cancer Center, Ann Arbor
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 26-Wax-2026 · NCT06225427

Prediction Augmented Screening Initiative

Namoota walitti qabaa jira
  • VA Ann Arbor Healthcare System, Ann Arbor, MI, Ann Arbor
Umuriin 50 hanga 80 · Saalaa hunda · Haaromfame 26-Wax-2026 · NCT06538636

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

Namoota walitti qabaa jiraSadarkaa 2
  • Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
  • Huron Gastroenterology PC, Ypsilanti · Miili 7 fagaatti
  • Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · Miili 7 fagaatti
  • fi 4 dabalataa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 03-Wax-2026 · NCT05642572

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

Namoota walitti qabaa jiraSadarkaa 2/3
  • Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · Miili 7 fagaatti
  • Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea · Miili 15 fagaatti
  • Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton · Miili 18 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Cam-2026 · NCT06616584

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

Namoota walitti qabaa jiraSadarkaa 2
  • Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
  • Huron Gastroenterology PC, Ypsilanti · Miili 7 fagaatti
  • Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · Miili 7 fagaatti
  • fi 4 dabalataa
18 Minutes · Saalaa hunda · Haaromfame 05-Cam-2026 · NCT06031688

A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1/2
  • University of Michigan, Ann Arbor
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Elb-2026 · NCT07020221

Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy

Namoota walitti qabaa jira
  • VA Ann Arbor Healthcare System, Ann Arbor, MI, Ann Arbor
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 19-Gur-2026 · NCT02984761

EZH2 Inhibitor, Tulmimetostat, and PD-1 Blockade for Treatment of Advanced Non-small Cell Lung Cancer

Namoota walitti qabaa jiraSadarkaa 1/2
  • VA Ann Arbor Healthcare System, Ann Arbor, MI, Ann Arbor
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 27-Ama-2026 · NCT05467748

A Self-Monitoring Platform for Tracking Medication Safety and Concerns in Cancer Patients

Namoota walitti qabaa jira
  • University of Michigan Comprehensive Cancer Center, Ann Arbor
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 21-Ama-2026 · NCT07291414

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Massive Bio SYNERGY-AI site, Ann Arbor
Umuriin hundi · Saalaa hunda · Haaromfame 28-Onk-2025 · NCT03452774

A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1/2
  • University of Michigan, Ann Arbor
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 24-Ful-2025 · NCT05941507

Qorannoo Dhibee Qara magaalota biroo keessatti

Qorannoo biroo Ann Arbor keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.